Want to see SSKN full AI Analyst Report?
SSKN Stock Chart & Stats
$0.09
<$0.01(10.00%)
At close: 4:00 PM EDT
$0.09
<$0.01(10.00%)
Day’s Range― - ―
52-Week Range$0.09 - $3.86
Previous CloseN/A
Volume71.58K
Average Volume (3M)7.72M
Market Cap
$29.44K
Enterprise Value$15.78
Total Cash (Recent Filing)$7.91M
Total Debt (Recent Filing)$16.27M
Price to Earnings (P/E)―
Beta-0.25
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.01
Shares Outstanding5,888,199
10 Day Avg. Volume10,725,031
30 Day Avg. Volume7,723,336
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)20.15
Price to Sales (P/S)1.91
P/FCF Ratio-13.75
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.29
Revenue Forecast (FY)$22.18M
Bulls Say, Bears Say
Bulls Say
Leadership And StrategyDr. Dolev Rafaeli was reappointed as CEO and has implemented a strategic turnaround plan focused on direct-to-consumer marketing to drive patient volume.
Market Growth PotentialSignificant opportunities in the dermatology market, with the potential for growth in the global treatment market expected to reach $44B by 2031.
Product AdvantagesThe FDA-cleared XTRAC therapy offers several advantages in the treatment of psoriasis, backed by peer-reviewed study data.
Bears Say
International RevenueThe 2Q25 revenue miss was primarily due to international weakness related to tariffs which could continue to pressure the topline through the remainder of 2025.
Strata Skin Sciences News
SSKN FAQ
What was Strata Skin Sciences Inc’s price range in the past 12 months?
Strata Skin Sciences Inc lowest stock price was $0.09 and its highest was $3.86 in the past 12 months.
What is Strata Skin Sciences Inc’s market cap?
Strata Skin Sciences Inc’s market cap is $29.44K.
When is Strata Skin Sciences Inc’s upcoming earnings report date?
Strata Skin Sciences Inc’s upcoming earnings report date is Nov 17, 2026 which is in 78 days.
How were Strata Skin Sciences Inc’s earnings last quarter?
Strata Skin Sciences Inc released its earnings results on Mar 24, 2026. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.26 by $0.27.
Is Strata Skin Sciences Inc overvalued?
According to Wall Street analysts Strata Skin Sciences Inc’s price is currently Overvalued.
Does Strata Skin Sciences Inc pay dividends?
Strata Skin Sciences Inc does not currently pay dividends.
What is Strata Skin Sciences Inc’s EPS estimate?
Strata Skin Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Strata Skin Sciences Inc have?
Strata Skin Sciences Inc has 5,888,199 shares outstanding.
What happened to Strata Skin Sciences Inc’s price movement after its last earnings report?
Strata Skin Sciences Inc reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.26. Following the earnings report the stock price went down -18.75%.
Which hedge fund is a major shareholder of Strata Skin Sciences Inc?
Currently, no hedge funds are holding shares in SSKN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Strata Skin Sciences Inc
STRATA Skin Sciences, Inc. is an innovative medical technology enterprise dedicated to the development, commercialization, and marketing of advanced products specifically designed for treating a range of dermatologic conditions. The company operates through two main divisions: Dermatology Recurring Procedures and Dermatology Procedures Equipment. With a substantial global footprint, STRATA Skin Sciences distributes its solutions across the United States, Europe, the Middle East, Asia, Australia, South Africa, and both Central and South America. Its notable product portfolio includes the XTRAC and Pharos excimer laser systems, VTRAC lamp systems, and TheraClear treatment solutions. These technologies are instrumental in addressing common skin ailments such as psoriasis, vitiligo, and acne, among others. Domestically, the company engages directly with physicians for product distribution, while leveraging a network of international distributors to reach markets beyond the U.S. Established in 1989 and headquartered in Horsham, Pennsylvania, the company adopted its current name, STRATA Skin Sciences, Inc., in January 2016, having previously operated as MELA Sciences, Inc.
Technical Analysis
Ownership Overview
0.15% Insiders
0.17% Mutual Funds
16.49% Other Institutional Investors
83.19% Public Companies and
Individual Investors